Loading clinical trials...
Loading clinical trials...
A Twelve-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study With Follow-up Evaluating The Safety And Efficacy Of Varenicline For Smoking Cessation In Healthy Adolescent Smokers
Conditions
Interventions
Varenicline 1mg BID
Varenicline 0.5mg BID
+1 more
Locations
80
United States
IICR, Inc. (DBA: International Institute of Clinical Research)
Ozark, Alabama, United States
Dedicated Clinical Research
Goodyear, Arizona, United States
Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
Little Rock, Arkansas, United States
Anaheim Clinical Trials, LLC
Anaheim, California, United States
Omega Clinical Trials, LLC
La Habra, California, United States
Synergy Clinical Research Center
National City, California, United States
Start Date
April 1, 2011
Primary Completion Date
January 1, 2018
Completion Date
January 1, 2018
Last Updated
August 9, 2018
NCT07441928
NCT05733767
NCT07061522
NCT06798324
NCT07013968
NCT06926608
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions